(Ankara Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Ankara, Türkiye)
Mücteba YAYLA
(Ankara Üniversitesi, Tıp Fakültesi, Romatoloji Anabilim Dalı, Ankara, Türkiye)
(Ankara Üniversitesi, Tıp Fakültesi, Radyoloji Anabilim Dalı, Ankara, Türkiye)
(Ankara Üniversitesi, Tıp Fakültesi, Radyoloji Anabilim Dalı, Ankara, Türkiye)
(Ankara Üniversitesi, Tıp Fakültesi, Romatoloji Bilim Dalı İç Hastalıkları Anabilim Dalı, Ankara, Türkiye)
Yıl: 2018Cilt: 26Sayı: 3ISSN: 2147-9291 / 2147-9291Sayfa Aralığı: 161 - 165İngilizce

60 0
A Rare Clinical Presentation of Behçet’s Disease with Life-Threatening Extensive Multiple Thrombosis and Recurrent Cardiac Arrest
Behçet’s disease (BD) is (also known as Behçet Syndrome) a chronic inflammatory disease with unknown etiology. Researchers continue to explore possible genetic, bacterial, viral and environmental causes of BD, is frequent among the Mediterranean, Middle East, and Far Eastern populations. Cardinal symptoms are composed of recurrent oral ulcer, genital ulcer, skin lesions and eye involvement. Musculoskeletal, neurological, gastrointestinal and vascular system can also be affected. Diagnosis of BD is made on the basis of the combination of clinical findings, and widely accepted criterion such as International Study Group (ISG) is used. However, some cases unfulfilled by the criteria are not uncommon in the endemic geographical regions like Turkey and ‘Silk-road’ countries. Here we report a case of 15-year old male who presented with life-threatening multiple thrombosis and who had no signs which met any of the criteria making its diagnosis challenging
Dergititle.paper.fact_presentationErişime Açık
  • 1. Yazici H, Fresko I, Yurdakul S. Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 2007;3(3):148-55.
  • 2. Düzgün N, Ateş A, Aydintuğ OT, Demir Ö, Olmez U. Characteristics of vascular involvement in Behçet's disease. Scand J Rheumatol 2006;35(1):65-83.
  • 3. International Study Group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335(8697):1078- 80.
  • 4. Koné-Paut I, Geisler I, Wechsler B, Ozen S, Ozdoğan H, Rozenbaum M, et al. Familial aggregation in Behçet’s disease: high frequency in siblings and parents of pediatric probands. J Pediatr 1999;135(1):89- 93.
  • 5. Verity DH,Marr JE, Ohno S, Wallace GR, Stanford MR. Behçet’s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 1999;54(3):213-20.
  • 6. Davatchi F, Assad-Khalil S, Calamia KT, Crook JE, Sadeghi-Abdollahi B, Schirmer M, et al. The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 2014;28(3):338-47.
  • 7. Kitaichi N, Ohno S. Behçet disease in children. Int Ophthalmol Clin 2008;48(3):87-91.
  • 8. Kitaichi N, Miyazaki A, Stanford MR, Iwata D, Chams H, Ohno S. Low prevalence of juvenile-onset Behçet’s disease with uveitis in East/South Asian people. Br J Ophthalmol 2009;93(11):1428-30.
  • 9. Calamia KT, Schirmer M, Melikoglu M. Major vessel involvement in Behçet disease. Curr Opin Rheumatol 2005;17(1):1-8.
  • 10. Leiba M, Seligsohn U, Sidi Y, Harats D, Sela BA, Griffin JH, et al. Thrombophilic factors are not the leading cause of thrombosis in Behçet’s disease. Ann Rheum Dis 2004;63(11): 1445-9.
  • 11. Ferro JM, Canhão P. Cerebral venous sinus thrombosis: update on diagnosis and management. Curr Cardiol Rep 2014;16(9): 523.
  • 12. Ahn JK, Lee YS, Jeon CH, Koh EM, Cha HS. Treatment of venous thrombosis associated with Behçet’s disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation. Clin Rheumatol 2008;27(2):201-5.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.